Reuters Health Stories

Living alone in mid-life raises risk of dementia later in life
NEW YORK (Reuters Health) - People who live alone in middle-age are significantly more likely to develop dementia and Alzheimer's disease in later life, compared with people who are married or cohabiting in mid-life, according to results of a study in the July 3 issue of BMJ Online First.
7/2/2009 7:01:20 PM

Anti-TNF therapy for rheumatoid arthritis safe at standard doses
NEW YORK (Reuters Health) - At recommended doses, anti-tumor necrosis factor (anti-TNF) treatments for rheumatoid arthritis do not increase the risk of serious adverse events, according to a report in the Annals of the Rheumatic Diseases for July.
7/2/2009 5:00:19 PM

Course of norovirus infection in preterm infants varies widely
NEW YORK (Reuters Health) - Norovirus infection in preterm infants can follow widely varying clinical courses, according to findings published online June 2nd in BMC Research Notes.
7/2/2009 4:40:19 PM

Hepatitis B virus mutations predict risk of hepatocellular carcinoma
NEW YORK (Reuters Health) - Specific hepatitis B virus (HBV) mutations are associated with development of hepatocellular carcinoma (HCC) and may help predict infected patients' risk for these tumors, according to a report published online July 2nd in the Journal of the National Cancer Institute.
7/2/2009 4:33:49 PM

Glaucoma patients overestimate their skill with eyedrops
NEW YORK (Reuters Health) - Although more than 90% of patients taking ocular hypotensive medication felt confident about aspects of their eyedrop instillation technique, less than a third actually demonstrated adequate skills in a study reported in the June issue of Archives of Ophthalmology.
7/2/2009 4:30:19 PM

Slovenian drug firm Krka's H1 sales up 2 percent
LJUBLJANA (Reuters) - Slovenian drug company Krka's group sales were up 2 percent in the first half of 2009 at 477.9 million euros ($674 million), the company said on Thursday.
7/2/2009 4:01:05 PM

ANALYSIS: Cost cutting in US to drive BPO healthcare business
BANGALORE (Reuters) - Outsourcing of healthcare services is expected to gain momentum as the prolonged slowdown forces U.S.-based government agencies and healthcare firms to cut spiraling costs and deal with a shortage in qualified personnel.
7/2/2009 4:00:56 PM

Addex seeks partners to help preserve cash
GENEVA (Reuters) - Swiss biotech group Addex is looking for partners to help develop several of its drugs, aiming to preserve its cash position through current tough refinancing markets, its chief executive told Reuters.
7/2/2009 4:00:47 PM

J&J buys $1 bln Elan stake, gains Alzheimer's R&D
BOSTON (Reuters) - Johnson & Johnson has agreed to pay $1 billion for an 18.4 percent stake in Irish drugmaker Elan Corp, and will acquire a major stake in Elan's portfolio of experimental drugs to treat Alzheimer's disease.
7/2/2009 4:00:19 PM

Britain projects 100,000 swine flu cases per day within months
LONDON (Reuters) - Britain is projecting more than 100,000 new cases a day of the H1N1 flu by the end of August and will change the way it deals with the virus, the government said on Thursday.
7/2/2009 3:28:49 PM

Kennedy, Dodd health plan cost drops to $611 billion
WASHINGTON (Reuters) - Key Senate Democrats said on Thursday the cost of their plan to overhaul the U.S. healthcare system has dropped to $611 billion over a decade, a figure they hope will help draw wider bipartisan support in Congress.
7/2/2009 3:23:19 PM

Obesity and smoking tied to myelodysplastic syndromes
NEW YORK (Reuters Health) - Although factors such as diet and alcohol consumption do not seem to affect the risk of myelodysplastic syndromes (MDS), tobacco use and body mass index (BMI) are associated with these conditions, researchers report in the June 15th issue of the American Journal of Epidemiology.
7/2/2009 3:16:19 PM

White-coat HTN, masked HTN linked to risk of sustained HTN
NEW YORK (Reuters Health) - People with white-coat hypertension (HTN) or masked HTN are at increased risk of developing sustained HTN, according to an article in the August issue of Hypertension.
7/2/2009 2:34:48 PM

Deep brain stimulation for Parkinson's disease influences mood
NEW YORK (Reuters Health) - Deep brain stimulation in the subthalamic nucleus (STN) or the globus pallidus interna (GPi) is associated with significant mood changes in patients with Parkinson's disease, according to a report in the May issue of the Annals of Neurology.
7/2/2009 1:46:18 PM

ST-246 protects primates from smallpox, monkeypox
NEW YORK (Reuters Health) - ST-246, a novel orthopoxvirus egress inhibitor, protects nonhuman primates from challenges with smallpox or monkeypox virus, according to a report in the June Antimicrobial Agents and Chemotherapy.
7/2/2009 1:09:48 PM

Statins, ACE inhibitors may lower mortality after COPD exacerbations
NEW YORK (Reuters Health) - Use of statins and angiotensin converting-enzyme (ACE) inhibitors is associated with lower mortality after acute exacerbations of chronic obstructive pulmonary disease (COPD), according to a report in the June 3rd Respiratory Research.
7/2/2009 12:34:18 PM

Replacing enzymes helps cardiac performance in Anderson-Fabry disease
NEW YORK (Reuters Health) - Long-term enzyme-replacement therapy (ERT) significantly reduces left ventricular (LV) hypertrophy, improves cardiac performance, and ameliorates clinical symptoms in patients with Anderson-Fabry disease.
7/2/2009 12:27:48 PM

Nursing-home pneumonia can be treated as community-acquired
NEW YORK (Reuters Health) - Patients hospitalized with nursing home-acquired pneumonia have similar outcomes whether treated according to 2003 guidelines for community-acquired pneumonia or 2005 guidelines for healthcare-associated (HCA) pneumonia, according to a report in the June Journal of the American Geriatrics Society.
7/2/2009 12:25:48 PM

Sanofi wins FDA approval for Multaq for atrial fibrillation, flutter
PARIS (Reuters) - Sanofi-Aventis won approval to sell Multaq (dronedarone) in the United States. The Food and Drug Administration (FDA) cleared Multaq twice-daily 400 mg tablets to reduce the risk of cardiovascular hospitalisation in patients with atrial fibrillation or atrial flutter, Sanofi said on Thursday.
7/2/2009 11:04:17 AM

Addex seeks partners to help preserve cash
GENEVA (Reuters) - Swiss biotech group Addex is looking for partners to help develop several of its drugs, aiming to preserve its cash position through current tough refinancing markets, its chief executive told Reuters.
7/2/2009 11:00:35 AM

PAGE  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65  66  67  68  69  70  71  72  73  74  75  76  77  78  79  80  81  82  83  84  85  86  87  88  89  90  91  92  93  94  95  96  97  98  99  100  101  102  103  104  105  106  107  108  109  110  111  112  113  114  115  116  117  118  119  120  121  122  123  124  125  126  127  128  129  130  131  132  133  134  135  136  137  138  139  140  141  142  143  144  145  146  147  148  149  150  151  152  153  154  155  156  157  158  159  160  161  162  163  164  165  166  167  168  169  170  171  172  173  174  175  176  177  178  179  180  181  182  183  184  185  186  187  188  189  190  191  192  193  194  195  196  197  198  199  200  201  202  203  204  205  206  207  208  209  210  211  212  213  214  215  216  217  218  219  220  221  222  223  224  225  226  227  228  229  230  231  232  233  234  235  236  237  238  239  240  241  242  243  244  245  246  247  248  249  250  251  252  253  254  255  256  257  258  259  260  261  262  263  264  265  266  267  268  269  270  271  272  273  274  275  276  277  278  279  280  281  282  283  284  285  286  287  288  289  290  291  292  293  294  295  296  297  298  299  300  301  302  303  304  305  306  307  308  309  310  311  312  313  314  315  316  317  318  319  320  321  322  323  324  325  326  327  328  329  330  331  332  333  334  335  336  337  338  339  340  341  342  343  344  345  346  347  348  349  350  351  352  353  354  355  356  357  358  359  360  361  362  363  364  365  366  367  368  369  370  371  372  373  374  375  376  377  378  379  380  381  382  383  384  385  386  387  388  389  390  391  392  393  394  395  396  397  398  399  400  401  402  403  404  405  406  407  408  409  410  411  412  413  414  415  416  417  418  419  420  421  422  423  424  425  426  427  428  429  430  431  432  433  434  435  436  437  438  439  440  441  442  443  444  445  446  447  448  449  450  451  452  453  454  455  456  457  458  459  460  461  462  463  464  465  466  467  468  469  470  471  472  473  474  475  476  477  478  479  480  481  482  483  484  485  486  487  488  489  490  491  492  493  494  495  496  497  498  499  500  501  502  503  504  505  506 

LOOKING FOR EXPERT ADVICE? Experts here are available to answer all your questions! Please contact us for more information about this feature, or to become an expert.

MEDIA CENTER Interactive Media  Blogs  · AAA Convention Blog  · ADA Convention Blog  Hearing Archives  · Hearing Review - Jun 2009  · Hearing Review - May 2009  · Hearing Review - Apr 2009  · Hearing Review - Mar 2009  · Hearing Review - Feb 2009  · Hearing Review - All Archives  · Hearing Products - May 2009  · Hearing Products - Mar 2009  · Hearing Products - Feb 2009  · Hearing Products - Jan 2009  · Hearing Products - Nov 2008  · Hearing Products - All Archives  Newsletter  · The Insider  · Monthly Top Ten  Videos  · Batteries & Earmolds  · Hearing Aids  · Business & Marketing  · Hearing Testing  · Miscellaneous   Podcast Series  · Science Technology Thursday  · New Audiometric Technician/Hearing Aid Dispenser Online Program at Bellevue University  · What is AudioLinguistics?  · Hearing Aid Assistance Tax Credit Podcast Series  · 2009 AAA Previews  · 2009 AAA Follow Ups Resources Classifieds Calendar Consumer Resources Media Kit Advertiser Index EAB Reprints Submit an Article